The ETS Transcription Factor ESE-1 Transforms MCF-12A Human Mammary Epithelial Cells via a Novel Cytoplasmic Mechanism

REFERENCES

• Andreoli, J. M., Jang S. I., Chung E., Coticchia C. M., Steinert P. M., and Markova N. G.. 1997. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res. 25:4287–4295.
   PubMedGoogle Scholar
• Asada, S., Choi Y., and Uesugi M.. 2003. A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction. J. Am. Chem. Soc. 125:4992–4993.
   PubMed Web of Science ®Google Scholar
• Asada, S., Choi Y., Yamada M., Wang S. C., Hung M. C., Qin J., and Uesugi M.. 2002. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proc. Natl. Acad. Sci. USA 99:12747–12752.
   PubMed Web of Science ®Google Scholar
• Boulukos, K. E., Pognonec P., Rabault B., Begue A., and Ghysdael J.. 1989. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9:5718–5721.
   PubMed Web of Science ®Google Scholar
• Cabral, A., Fischer D. F., Vermeij W. P., and Backendorf C.. 2003. Distinct functional interactions of human Skn-1 isoforms with Ese-1 during keratinocyte terminal differentiation. J. Biol. Chem. 278:17792–17799.
   PubMedGoogle Scholar
• Chang, C. H., Scott G. K., Baldwin M. A., and Benz C. C.. 1999. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP). Oncogene 18:3682–3695.
   PubMedGoogle Scholar
• Chang, C. H., Scott G. K., Kuo W. L., Xiong X., Suzdaltseva Y., Park J. W., Sayre P., Erny K., Collins C., Gray J. W., and Benz C. C.. 1997. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 14:1617–1622.
   PubMed Web of Science ®Google Scholar
• Chiang, S. Y., Burli R. W., Benz C. C., Gawron L., Scott G. K., Dervan P. B., and Beerman T. A.. 2000. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. J. Biol. Chem. 275:24246–24254.
   PubMed Web of Science ®Google Scholar
• Choi, S. G., Yi Y., Kim Y. S., Kato M., Chang J., Chung H. W., Hahm K. B., Yang H. K., Rhee H. H., Bang Y. J., and Kim S. J.. 1998. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor. J. Biol. Chem. 273:110–117.
   PubMed Web of Science ®Google Scholar
• Choi, Y., Asada S., and Uesugi M.. 2000. Divergent hTAFII31-binding motifs hidden in activation domains. J. Biol. Chem. 275:15912–15916.
   PubMedGoogle Scholar
• Cifone, M. A. 1982. In vitro growth characteristics associated with benign and metastatic variants of tumor cells. Cancer Metastasis Rev. 1:335–347.
   PubMedGoogle Scholar
• Cohen, B. D., Siegall C. B., Bacus S., Foy L., Green J. M., Hellstrom I., Hellstrom K. E., and Fell H. P.. 1998. Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma. Biochem. Soc. Symp. 63:199–210.
   PubMedGoogle Scholar
• De Haro, L., and Janknecht R.. 2002. Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res. 30:2972–2979.
   PubMedGoogle Scholar
• Delannoy-Courdent, A., Mattot V., Fafeur V., Fauquette W., Pollet I., Calmels T., Vercamer C., Boilly B., Vandenbunder B., and Desbiens X.. 1998. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J. Cell Sci. 111:1521–1534.
   PubMed Web of Science ®Google Scholar
• Delattre, O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G., et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165.
   PubMed Web of Science ®Google Scholar
• de Martin, R., Schmid J. A., and Hofer-Warbinek R.. 1999. The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutat. Res. 437:231–243.
   PubMedGoogle Scholar
• Ducret, C., Maira S. M., Dierich A., and Wasylyk B.. 1999. The net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock. Mol. Cell. Biol. 19:7076–7087.
   PubMedGoogle Scholar
• Eckel, K. L., Tentler J. J., Cappetta G. J., Diamond S. E., and Gutierrez-Hartmann A.. 2003. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression. DNA Cell Biol. 22:79–94.
   PubMed Web of Science ®Google Scholar
• Feldman, R. J., Sementchenko V. I., and Watson D. K.. 2003. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res. 23:2125–2131.
   PubMed Web of Science ®Google Scholar
• Fukuda, M., Gotoh I., Gotoh Y., and Nishida E.. 1996. Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:20024–20028.
   PubMedGoogle Scholar
• Grall, F., Gu X., Tan L., Cho J. Y., Inan M. S., Pettit A. R., Thamrongsak U., Choy B. K., Manning C., Akbarali Y., Zerbini L., Rudders S., Goldring S. R., Gravallese E. M., Oettgen P., Goldring M. B., and Libermann T. A.. 2003. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 48:1249–1260.
   PubMed Web of Science ®Google Scholar
• Janknecht, R., Zinck R., Ernst W. H., and Nordheim A.. 1994. Functional dissection of the transcription factor Elk-1. Oncogene 9:1273–1278.
   PubMedGoogle Scholar
• Jobling, A. I., Fang Z., Koleski D., and Tymms M. J.. 2002. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 43:3530–3537.
   PubMedGoogle Scholar
• Kapuscinski, J. 1995. DAPI: a DNA-specific fluorescent probe. Biotechnol. Histochem. 70:220–233.
   PubMed Web of Science ®Google Scholar
• Kas, K., Finger E., Grall F., Gu X., Akbarali Y., Boltax J., Weiss A., Oettgen P., Kapeller R., and Libermann T. A.. 2000. ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J. Biol. Chem. 275:2986–2998.
   PubMedGoogle Scholar
• Le Gallic, L., Sgouras D., Beal G., Jr., and Mavrothalassitis G.. 1999. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol. Cell. Biol. 19:4121–4133.
   PubMed Web of Science ®Google Scholar
• Leprince, D., Gegonne A., Coll J., de Taisne C., Schneeberger A., Lagrou C., and Stehelin D.. 1983. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306:395–397.
   PubMed Web of Science ®Google Scholar
• Lopez, R. G., Carron C., and Ghysdael J.. 2003. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6). J. Biol. Chem. 278:41316–41325.
   PubMedGoogle Scholar
• Neve, R., Chang C. H., Scott G. K., Wong A., Friis R. R., Hynes N. E., and Benz C. C.. 1998. The epithelium-specific ets transcription factor ESX is associated with mammary gland development and involution. FASEB J. 12:1541–1550.
   PubMedGoogle Scholar
• Neve, R. M., Ylstra B., Chang C. H., Albertson D. G., and Benz C. C.. 2002. ErbB2 activation of ESX gene expression. Oncogene 21:3934–3938.
   PubMedGoogle Scholar
• Neznanov, N., Man A. K., Yamamoto H., Hauser C. A., Cardiff R. D., and Oshima R. G.. 1999. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Res. 59:4242–4246.
   PubMed Web of Science ®Google Scholar
• Ng, A. Y., Waring P., Ristevski S., Wang C., Wilson T., Pritchard M., Hertzog P., and Kola I.. 2002. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 122:1455–1466.
   PubMedGoogle Scholar
• Niswender, K. D., Blackman S. M., Rohde L., Magnuson M. A., and Piston D. W.. 1995. Quantitative imaging of green fluorescent protein in cultured cells: comparison of microscopic techniques, use in fusion proteins and detection limits. J. Microsc. 180:109–116.
   PubMed Web of Science ®Google Scholar
• Oettgen, P., Alani R. M., Barcinski M. A., Brown L., Akbarali Y., Boltax J., Kunsch C., Munger K., and Libermann T. A.. 1997. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol. Cell. Biol. 17:4419–4433.
   PubMed Web of Science ®Google Scholar
• Oettgen, P., Kas K., Dube A., Gu X., Grall F., Thamrongsak U., Akbarali Y., Finger E., Boltax J., Endress G., Munger K., Kunsch C., and Libermann T. A.. 1999. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes. J. Biol. Chem. 274:29439–29452.
   PubMed Web of Science ®Google Scholar
• Oikawa, T., and Yamada T.. 2003. Molecular biology of the Ets family of transcription factors. Gene 303:11–34.
   PubMed Web of Science ®Google Scholar
• Oren, M. 2003. Decision making by p53: life, death and cancer. Cell Death Differ. 10:431–442.
   PubMed Web of Science ®Google Scholar
• Reddy, S. P., Vuong H., and Adiseshaiah P.. 2003. Interplay between proximal and distal promoter elements is required for squamous differentiation marker induction in the bronchial epithelium: role for ESE-1, Sp1, and AP-1 proteins. J. Biol. Chem. 278:21378–21387.
   PubMedGoogle Scholar
• Rhim, J. S. 2001. Molecular and genetic mechanisms of prostate cancer. Radiat. Res. 155:128–132.
   PubMedGoogle Scholar
• Sapi, E., Flick M. B., Rodov S., and Kacinski B. M.. 1998. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res. 58:1027–1033.
   PubMed Web of Science ®Google Scholar
• Schedin, P. J., Eckel-Mahan K. L., McDaniel S. M., Prescott J. D., Brodsky K. S., Tentler J. J., and Gutierrez-Hartmann A.. 2004. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Oncogene 9:1766–1779.
   Google Scholar
• Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell. Biol. 2:827–837.
   PubMed Web of Science ®Google Scholar
• Soule, H. D., Maloney T. M., Wolman S. R., Peterson W. D., Jr., Brenz R., McGrath C. M., Russo J., Pauley R. J., Jones R. F., and Brooks S. C.. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075–6086.
   PubMed Web of Science ®Google Scholar
• Teruyama, K., Abe M., Nakano T., Iwasaka-Yagi C., Takahashi S., Yamada S., and Sato Y.. 2001. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J. Cell. Physiol. 188:243–252.
   PubMedGoogle Scholar
• Tootle, T. L., Lee P. S., and Rebay I.. 2003. CRM1-mediated nuclear export and regulated activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions with MAE. Development 130:845–857.
   PubMedGoogle Scholar
• Trempe, G. L. 1976. Human breast cancer in culture. Recent Results Cancer Res. 57:33–41.
   Google Scholar
• Tugores, A., Le J., Sorokina I., Snijders A. J., Duyao M., Reddy P. S., Carlee L., Ronshaugen M., Mushegian A., Watanaskul T., Chu S., Buckler A., Emtage S., and McCormick M. K.. 2001. The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades. J. Biol. Chem. 276:20397–20406.
   PubMedGoogle Scholar
• Tymms, M. J., Ng A. Y., Thomas R. S., Schutte B. C., Zhou J., Eyre H. J., Sutherland G. R., Seth A., Rosenberg M., Papas T., Debouck C., and Kola I.. 1997. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene 15:2449–2462.
   PubMed Web of Science ®Google Scholar
• Vermes, I., Haanen C., Steffens-Nakken H., and Reutelingsperger C.. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39–51.
   Google Scholar
• Vida, T. A., and Emr S. D.. 1995. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol. 128:779–792.
   PubMed Web of Science ®Google Scholar
• Wasylyk, B., Hagman J., and Gutierrez-Hartmann A.. 1998. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 23:213–216.
   PubMed Web of Science ®Google Scholar
• Wolvetang, E. J., Wilson T. J., Sanij E., Busciglio J., Hatzistavrou T., Seth A., Hertzog P. J., and Kola I.. 2003. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum. Mol. Genet. 12:247–255.
   PubMedGoogle Scholar
• Yamada, T., and Oikawa T.. 1997. Induction of apoptosis by overexpression of the PU.1/Spi-1 gene in murine erythroleukemia cells. Leukemia 11(Suppl. 3):480–481.
   PubMedGoogle Scholar
• Yoneda, Y. 1997. How proteins are transported from cytoplasm to the nucleus. J. Biochem. (Tokyo) 121:811–817.
   PubMedGoogle Scholar
• Yoshida, N., Yoshida S., Araie M., Handa H., and Nabeshima Y.. 2000. Ets family transcription factor ESE-1 is expressed in corneal epithelial cells and is involved in their differentiation. Mech. Dev. 97:27–34.
   PubMedGoogle Scholar